MedTrace Logo

The Effects of Carnitine Supplementation on Oocytes in Women Undergoing IVF Process

NCT07783399 · Status: RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 70

Last updated 2026-08-24

No results posted yet for this study

Summary

The goal of this clinical trial is to learn whether supplementation with L-carnitine improves outcomes in women undergoing in vitro fertilization (IVF). It will also evaluate the effect of supplementation on oocyte quality, embryo quality, and pregnancy rates. The main questions it aims to answer are:

* Does supplementation improve the number and quality of oocytes retrieved during IVF treatment?
* Does supplementation improve the number and quality of embryos obtained after fertilization?
* Does supplementation increase the rates of biochemical and clinical pregnancy?

Researchers will compare women receiving supplementation with women not receiving supplementation to determine whether the supplements improve IVF outcomes.

Conditions

  • Infertility (IVF Patients)

Interventions

DIETARY_SUPPLEMENT

L-Carnitine Group

A supplementation group will receive L-carnitine (500 mg) daily for 12 weeks before oocyte retrieval.

Sponsors & Collaborators

  • The Obstetrics and Gynaecology Clinic Narodni Front

    lead OTHER

Study Design

Allocation
RANDOMIZED
Purpose
BASIC_SCIENCE
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
45 Years
Sex
FEMALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2026-05-15
Primary Completion
2026-09-01
Completion
2026-09-20

Countries

  • Serbia

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT07783399 on ClinicalTrials.gov